SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 263 filers reported holding SAGE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,622,430 | -57.7% | 176,017 | -3.3% | 0.07% | -54.7% |
Q2 2023 | $8,557,076 | +9.1% | 181,988 | -2.7% | 0.15% | -7.5% |
Q1 2023 | $7,845,891 | +19.8% | 186,985 | +8.9% | 0.16% | +11.9% |
Q4 2022 | $6,551,727 | -0.9% | 171,781 | +1.8% | 0.14% | -5.9% |
Q3 2022 | $6,609,000 | +17.3% | 168,766 | -3.2% | 0.15% | +23.6% |
Q2 2022 | $5,633,000 | -3.8% | 174,398 | -1.4% | 0.12% | +18.3% |
Q1 2022 | $5,857,000 | -23.0% | 176,949 | -1.1% | 0.10% | -20.6% |
Q4 2021 | $7,610,000 | -3.6% | 178,892 | +0.4% | 0.13% | -10.3% |
Q3 2021 | $7,898,000 | +78.3% | 178,241 | +128.6% | 0.15% | +82.5% |
Q2 2021 | $4,430,000 | -23.1% | 77,973 | +1.3% | 0.08% | -27.3% |
Q1 2021 | $5,764,000 | -21.3% | 77,005 | -9.1% | 0.11% | -26.2% |
Q4 2020 | $7,326,000 | +32.7% | 84,685 | -6.2% | 0.15% | +13.7% |
Q3 2020 | $5,520,000 | +41.1% | 90,320 | -4.0% | 0.13% | +36.5% |
Q2 2020 | $3,911,000 | – | 94,060 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |